Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Ranks in Top Ten of Deloitte Tech Fast 500 Asia Pacific Winners

December 09, 2004 - Shanghai, China - International accounting giant Deloitte & Touche today announced winners of the prestigious Deloitte Technology Fast 500 Asia Pacific annual competition.. WuXi PharmaTech Co. Ltd., China's leading chemistry-based pharmaceutical research and development service company, ranked ninth among the 500 winners.

Deloitte's program recognizes the fastest-growing technology companies from countries across the Asia Pacific region including Australia, China/Hong Kong, India, Japan and many other countries.This year's 500 winners achieved an impressive average revenue growth of 400 percent over the past three years. Included the 2004 Technology Fast 500 Asia Pacific list are 145 companies from China (including Hong Kong, Taiwan), accounting for 29 percent of honorees. Three of the top ten winners, Fiberxon Technology (Shenzhen) Co., Ltd, WuXi PharmaTech Co., Ltd. and NetEase.com.Inc., are from China.

Dr Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, said: "We're honored to be included in such distinguished company as the 500 winners of Deloitte's Fast 500 program.To be ranked 9th among this extraordinary group of achievers exceeded our expectations and is deeply motivating to our entire staff.We are grateful to our collaboration partners who have been integral to the growth of our company. Clearly they are central to why we were chosen for this award. We remain focused on improving the breadth and depth of our product offerings and serving our customers and partners better."

About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.

back to top